Corporates Lyka Labs receives CDSCO approval to manufacture and market Pregabalin Gel 8% w/w… Aman Shukla Oct 14, 2024
Medical Zydus and ICMR initiate Phase 2 trial of Desidustat for Sickle Cell Disease News Desk Oct 14, 2024
Corporates Zydus Lifesciences receives USFDA approval for Paliperidone Extended-Release… Aman Shukla Oct 10, 2024
Corporates Dr. Reddy’s Laboratories subsidiary announces promising Phase 1 results for… Aman Shukla Oct 8, 2024
Corporates Emcure Pharmaceuticals signs licensing agreement with Gilead for manufacture and… Aman Shukla Oct 3, 2024
Corporates Alembic Pharmaceuticals receives USFDA final approval for Lamotrigine… News Desk Oct 3, 2024
Corporates Dr Reddy’s Laboratories signs licensing deal with Gilead Sciences to… Aman Shukla Oct 2, 2024
Corporates HealthCare Global Enterprises completes acquisition of 51% stake in Vizag Hospital News Desk Oct 2, 2024
Corporates Zydus Lifesciences gets tentative approval from USFDA for Enzalutamide Tablets, 40… Aman Shukla Oct 2, 2024
Corporates SMS Pharmaceuticals receives EDQM certification to supply Ibuprofen in Europe News Desk Oct 1, 2024
Corporates Jubilant Pharmova receives “Official Action Indicated” notice from USFDA for… News Desk Sep 28, 2024
Corporates Aster DM Healthcare to establish new women & children hospital in Hyderabad News Desk Sep 22, 2024
Medical A Guide to Chronic Pain Management: Coping Strategies and Common Treatments News Desk Aug 30, 2024
Corporates Zydus Lifesciences receives US FDA approval for Scopolamine Patch, eyeing $69.6… News Desk Aug 30, 2024
Corporates Natco Pharma submits ANDA for generic version of Tabrecta, a $126M US market drug News Desk Aug 29, 2024
